Outpatient Evaluation of Patients With Known or Suspected Heart Disease - Full Text View

Sponsored by:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:	NCT00001400

Purpose

This study is designed to screen patients with heart diseases who may qualify to participate in other research studies being conducted by the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI).

Patients participating in this research study will be seen on an outpatient basis and undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test.

Patients participating in this study will not receive any investigational treatments.

Condition
Heart Disease

MedlinePlus related topics: Heart Diseases

U.S. FDA Resources

Study Type:	Observational
Official Title:	Outpatient Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)

Further study details as provided by National Institutes of Health Clinical Center (CC):

Study Start Date:	December 1993
Estimated Study Completion Date:	December 2001

Detailed Description:

This protocol permits outpatient screening of patients with cardiovascular diseases who may be candidates for participation in current Cardiology Branch research protocols. No investigational treatments will be administered on this protocol.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Must not be enrolled in an active Cardiology Branch research protocol.

The patient must be of scientific interest to the Cardiology Branch, as determined by the investigator.

Patient is being screened for participation in an active protocol.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001400

Locations

United States, Maryland
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

More Information

Study ID Numbers:	940045, 94-H-0045
Study First Received:	November 3, 1999
Last Updated:	March 4, 2008
ClinicalTrials.gov Identifier:	NCT00001400
Health Authority:	United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):

Heart Disease
Screening
Follow-Up

Study placed in the following topic categories:

Heart Diseases

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 13, 2009